glp-1 breast cancer A trio of large observational studies reported at the San Antonio Symposium (SABCS) 2025 suggest that receptor agonists may improve outcomes in some women with breast cancer. Two studies Breast cancer very scary. GLP1

Theranostics 8(3):593609 van der Velde AR, Gullestad L, Ueland T, Aukrust P, Guo Y, Adourian A, Muntendam P, van Veldhuisen DJ, de Boer RA (2013) Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH

2021 Oct;9(20):1547

The big advantage

Eli Lilly recently published preliminary results from a 68-week retatrutide study, where 445 overweight adults (average BMI 40

mtROS further contributes to vascular remodeling by inducing smooth muscle cell proliferation and endothelial apoptosis via oxidative DNA damage (8-OHdG) and lipid peroxidation (MDA)

How do GLP-1 medications work to reduce appetite and promote weight loss